A few weeks ago, on this channel,

Winston here showed you four small

stocks before anybody was really paying

attention. One was Redwire, which this

one kicked ass and did 63% up. Whoops,

86% up on Voyager, 69% up on Firefly.

And that happened in just weeks. And

today, I'm going to show you six stocks,

but Winston here believes

are the last easy wealth-building

opportunities left in 2026.

Two of them are backed by billions in

government money. Two of them are

invisible infrastructure behind every AI

company you've ever heard of. And one is

a cloud giant that Wall Street just

keeps underestimating. And one, my

personal favorite, is a stock that

almost nobody talks about in an industry

that could be bigger than AI itself. And

I'm saving that one for last. Oh, and

one of the six, I just bought it with my

own money. I'm going to tell you which

one that is before the video ends. We

didn't hold you hostage. There are

timestamps, you can obviously jump

around. You can read the description.

So, if you are someone who just wants to

know the stock tickers, um I wish you

luck.

>> [laughter]

>> Because some of these stocks are

less risky. Some of these are extremely

risky. And I'm going to tell you which

is which according to my humble opinion.

And I'm going to also show you the

three-part framework I use to decide

whether a stock deserves your money or

it is just hype dressed up in a press

release. Cuz I strongly believe in not

giving you fish, cuz they go smelly in a

few days, but actually teaching you how

to fish. My name is Felix Brych, I'm an

ex-investment banker. That down here,

Winston, come on, sit.

Sit.

Sit up. Sit up.

Good boy. Stay.

This here is Winston, the brains behind

it all. And we've taught what, 25,000

students or something like that, which

is super, super rewarding. And today,

I'm going going you the same kind of

breakdown that I've given you for some

of the other stocks. Now, does that mean

these guys are going to go up 100%? No,

of course not. I'm not a financial

advisor. I haven't got a crystal ball.

You got to come to your own conclusions,

right? This is the most important bit.

But the video's also going to be pretty

dense in terms of information, a little

bit more than some people can process.

So, I'm going to put the six stocks, the

real numbers, the real risk to make sure

it really lands for you all together in

a full bonus research report which

covers everything actually plus more

that we just don't have time for in the

video. You can download that for free at

felixfriends.org/sixstocks.

felixfriends.org/sixstocks. The link is

in the description

down below. So, before we dive deep into

the six stocks, let me show you the

framework because

I don't want you to memorize ticker

lists. I don't want you to buy things

because some guy on YouTube with a very

cute dog is talking about it. That's not

really how we get to financial freedom.

I want you to understand how to evaluate

any stock. It's these six here, the next

six, or whatever comes after that. So, I

use these three filters here.

Filter number one, so we're looking at

growth stocks. Do they have a cash

runway? Can they survive for a couple of

years without having to sell more shares

to raise money?

Because when a company doesn't have a

lot of cash and they sell new shares,

they call it dilution. It means your

slice of the pie gets smaller and

smaller and smaller. So, they're the

Ozempic for shareholders, but not in a

good way. Just side effects. Filter

number two is the institutional

tailwind.

And what I'm looking for is there a big

structural force like a government

spending, new regulations, or maybe

changing index fund rules like what we

discussed with SpaceX the other day.

Does that create mandatory buying

pressure? I'm not talking about hype.

I'm talking about situations where large

pools of money are forced to flow into a

stock whether it really wants to or not.

That's That's ticker item number two.

And item number three is revenue

inflection. I thought the word

inflection made me sound smarter. Is

this company crossing the line from sort

of interesting to showing real revenue

growth? Because Wall Street will

tolerate a money-losing company for a

while, but the moment revenue starts to

really speed up, it's typically when the

big money moves in. And if a stock

passes all three of these filters,

it goes on my watch list. If it fails on

one of them,

I want to understand exactly why I ever

put a single dollar into it. So, let me

show you how each of these six stocks

scores, tell you the one I bought, I

tell you the one that's my favorite. But

before I get into the stocks, let me ask

you something. And be honest with

yourself. Have you ever bought a huge

winner

too late?

You saw the stock, you knew it was good,

you watched it run up, and by the time

you finally bought it,

the easy money was already gone. Or

worse, have you ever held a stock and

watched your savings just slowly

disappear into Wall Street's pockets?

Week after week, red, red, and more red.

And you keep kept telling yourself,

"It'll come back."

And by the time you finally sold, the

damage was done, right?

Now, that's not bad luck.

That's the gap between knowing what to

buy and knowing how to actually make

money from it. And closing that gap is

the single most important thing you can

do as an investor. And that's why I'm

going to do something for you this

weekend on Saturday that's better than

this video. I'm going to run a live

free [snorts] session one time

where I will walk you through the

playbook that sits behind everything

about to show you. It's called the

greatest stock market playbook. And the

link is in the description down below.

Go to greatestplaybook.com.

Grab yourself a free seat, bring pen and

paper and an open mind and I will teach

you for

an and a half two hours Wall Street's

playbook for exactly what's going on in

the market right now so you can benefit

from what's coming in the next couple of

months and apply it year after year

after that, right?

But let's start with

our stocks.

Let's start with the most exciting, uh

the most riskiest uh on our list. Both

of these stocks are backed by billions

and government money. Both of them are

in industries most people think are

science fiction and both of them could

either make you a fortune or go to zero.

So, very, very important to understand

how to play risk management on this. The

first stock is called Beta Technologies,

ticker symbol Beta or Beta depending on

where you are in the world. What do they

make? Electric aircraft. Not drones,

full-size planes, full-size planes that

take off and land vertically like a

helicopter. But they fly like a jet.

They call it eVTOLs,

and landing.

I know who came up with that, right?

Sort of

the Tesla for the sky.

Now, let's run through the filters here.

And if you're wondering where I get my

data from by the way, we have a Winston

app which of course Winston here built

for us. Where is Winston?

He's down here. Winston, come on.

Come on, tell us about the Winston app.

Come on, sit up. Up up up up. Winst Hey,

sit up. Come here. He's too tired. He

doesn't want to get up. Uh but Winston

built an app and we called it the

Winston app

and it gives you all that data. Um and

here if I pull up Beta Technologies, it

says no score yet. Winston is napping

which is actually 100% point on which

because it's a it's a it's an

early-stage business. But they build

electric aircraft. Revenue growth is

there, reasonable, 30% a year.

They're spending loads of money on R&D

which is actually what you want in a

growth company. Um 26% more than last

year.

And they have 3 years of cash on hand.

So, I'm quite happy with that, right?

Now, looking into the detailed data

doesn't really work when it's a growth

company, so I'm showing it to you cuz

it's kind of a kind of helpful to see.

And this is a stock that only went

public in November. And if you love

IPOs, uh this is a little bit of a of a

warning signal. It IPO'd around here

and is presently down 50% from the IPO

price. Woohoo.

Um

now, there is one thing on the screen

that I quite like the look of.

And of course, it isn't the fact that

it's down 50%. It is the fact that the

stock is doing this. You know, I'll go

through that in a lot more detail on the

weekend if you join me there at um on

Saturday. And I have a low. I have

another low. I have another low at

exactly the same place. And I also highs

in the same place. So, we're trading in

this

what I call a heartbeat pattern.

And that's actually the setup that we

look for. It's a setup that Wall

Street's been looking for for 50 years.

And once you understand that, you kind

of think, "Well, if we break out of this

zone here, especially with lots of money

pouring in, then this could actually be

an interesting play."

But in summary, cash looking good. The

institutional tailwind is this.

The FAA, the federal agency that

controls flying things, um maybe not

UFOs and birds, but everything else,

they launched a program called EIPP.

Sorry for all the acronyms. Uh and that

fast-tracks electric aircraft

certification. And there were eight

slots

available. Beta or Beta was selected for

seven of them. So, they got seven out of

the eight slots. Literally no other

company is is able to do anything else.

On top of that, they have, as I say, the

the the money and they have also

aircraft orders of 3.9 billion dollars

on the books. And the customers are

people like UPS, United Therapeutics.

They've committed to buying 991

aircraft, 991 of these guys. GE

Aerospace just partnered with them to

develop a hybrid electric turbo

generator that extends their range. Um

they're also building

the charging stations. We've got 123

charging stations they've built cuz

these planes need to get charged. And

then the revenue inflection here, this

part here, I'm just like making an

absolute um

kicks breakfast of this chart here,

aren't I, of this slide. They brought in

10 million of revenue in the last

quarter. The full-year guidance is 39 to

40 million. So, for a company valued at

a full billion dollars, which is I think

where we're trading right now. Where is

it? Yeah, 4 billion dollars. 40 million

in revenue is sort of like

uh okay, guys, how did you get to this

valuation? So,

Beta essentially passed the first two

filters with flying colors, literally,

right? The revenue inflection point

though hasn't happened yet. This is a

pre-revenue company trading on

potential, right? So, the risk here is

very, very real. The technology works,

but scaling to manufacturing is a very,

very different challenge. We've seen

that in the EV game, right? Most EV

companies failed.

So, if you put money into Beta, you need

to be comfortable with some serious uh

what you'd call it volatility. It means

uh it could go up or down a lot. So,

this is high risk, high potential bet on

the future, essentially. Stock two on

Winston's list is Rigetti Computing. Uh

and this is really a shame that this

isn't Italian. Um

if you think of

Beta as the Tesla for the sky, Rigetti

is trying to be the Intel of quantum

computing. Now, I know quantum computing

sounds like something from a science

fiction movie. Uh although if you go

back to our

last quantum video, um

and

looked at the stocks at that point and

then decided entirely on your own that

you might want to own one of those,

you'd probably be sending me Christmas

cards. So, not promising you future

outcomes. Even though I was right in the

past, doesn't mean I'm going to be right

in the future, right? That's how it

works.

But, you know, the kind of computer you

you using to watch this on,

they process information

using zeros and ones. Lots of zeros and

ones. So, basically it's on off. Quantum

computers use something called

qubits.

And they can be on, off, or both at the

same time. It's sort of think of it like

a zero that doesn't really know what

gender it is, right? And I know that

sounds a little bit weird. Not the

gender thing, you know, people can do

whatever they want, but the the qubit

thing. But, it means they can solve

certain problems

millions of times faster than any

computer that exists today.

I think that analogy is probably the

least PC analogy you will hear on

quantum computing on YouTube. So, we're

talking about drug discovery, financial

modeling, cryptography, logistics,

science, problems that would take

supercomputers

thousands of years to solve, a quantum

computer could do them in hours.

So, Rigetti builds and designs these

quantum processors in-house. They just

launched something called the 108-qubit

Cepheus processor. Cepheus is a

constellation in the sky. It's this guy

here, which

I don't know if that makes you feel

better or worse about investing in this

stock. Let me know down below in the

comments. Try to write Try to spell

Cepheus. Um but, literally their quantum

computing is available on Amazon.

Now, if you're now checking your Amazon

Prime subscription, not that Amazon,

AWS, Amazon's cloud business. They also

have a contract with India's National

Supercomputing Agency. They have an

integration with Nvidia. So,

now we know all that, let's look at some

numbers.

And what I always do here, go to the

Winston app. I'll put a link down below

to those as well as as We have a There's

a free trial to it for the week.

Um look actually this is what we're

going to do. We're going to give you a

month free trial too. All right, just

play with it for a month. You get some

value in it, stick around. If you don't,

you just cancel it. So, you click on the

link down below

and it'll it'll probably still say 7

days, but then when you click on

checkout it'll say 30 days free. Uh I

promise you that. I'll I'll I'll change

that by the time this video is uploaded.

So, it's just a just a little bit of a

little bit of a you know feel good gift

here uh today. Um now

these guys are burning through about

20-30 million dollars of cash

uh a quarter.

And that gives them a pretty short

runway um which you'd think. Now, I

actually know something about them. They

hold

cash equivalent stuff and I will I will

make a note to update that

to make sure we give you guys the best

information out there. So, if you ever

see anything in the app that you're not

loving, please tell me. I will make it

better usually the same day. So, back to

my slide. 569 billion cash. So, they

have about a 5-year runway to burn

through money, which is pretty good.

Institutional tailwind, si senor,

because in May Rigetti received a letter

of intent for a $100 million

from the Chips Act. It said to uh "Dear

Rigetti, this is your Chips Act. I am

intending to send you $100 million." And

And that's part of a $2 billion

government initiative to build America's

quantum computing infrastructure. So,

the US government has essentially

decided that quantum computing is

uh important for national security,

because imagine Imagine if the Cubans

got your national got got quantum

computers and US didn't. Well, they'd

hack everything. Or all the North

Koreans, they'd hack everything and take

everybody's money. Um

Rigetti is one of the companies they're

founding. But that revenue inflection is

still an

because um they brought in how many how

much money last quarter? About 4 million

last quarter, right?

And and it's trading at 700 times sales.

So,

by every financial metric, this stock

makes absolutely no effing sense. And if

you are a buy and and hold till death do

us part kind of guy, you probably don't

want to be in this.

But if you are a little bit more of the

growth investor, then we get these

opportunities, and they typically start

with something that looks like this.

And then it went up

just a little bit. And what am I seeing

right now? We saw the same pattern here.

It's starting to break out of that.

Again, I'm not telling you to buy it,

obviously. I'm just highlighting

the way I look at this. And then it went

up like 200%. So, could do the same

thing. We're seeing some serious

institutional money pouring in here.

But again, it is high risk because

quantum computing might never work. I I

think it would, but I could be wrong on

that, right? If they get the might be

might become a pasta company, which is

really what it should have been in the

first place. So, this is Rigetti is the

most speculative stock on our list.

Government backing, real technology, and

so on. But both Better and Rigetti are

pre-revenue companies. Government

betting, long time horizon is required,

or rather very good risk management is

required, which might be another way of

looking at this. Now, stock number

three, and then we're going to get on to

the one that I actually just bought, and

on to the one that is kind of my secret

favorite here.

We all have all of us secret favorite,

don't we? We do, Winston. And you are

it. Stock number three is the Oracle.

Now, I know what you're thinking. It's a

boring database company my dad's IT

department uses. But Oracle might be the

most

underestimated AI story on the planet

right now.

Cuz what people don't understand is

this. Every AI model, every chatbot,

every image generator, every autonomous

vehicle system needs massive computing

infrastructure to run. Someone's going

to build the data centers, the cloud

platforms, the back backbone, all that

stuff. Nvidia makes the chips, but the

chips need a home. And Oracle is

building homes for chips that need

homes. It's sort of like a char what

>> [laughter]

>> the heck. Um, let's have a look at

Oracle's data here. First of all,

Winston gives it a score of 66 out of

100, which is okay. Decent business, he

says. Some strong pillars, some weaker.

Now,

I've also got in here insider buying.

And by insiders, I mean politicians.

Donald Trump has a $3 $3 million

exposure, according to his last filing.

You can see on the chart here, Ro

Khanna, who's a very good

I was going to say trader, um,

politicians.

>> [laughter]

>> He keeps buying this thing. So, you can

see all the buys and sells there. You

can see literally all of them. Um,

and revenue growth is accelerating.

Insiders own 40% of the company,

which is brilliant. Cuz what you what

you what you what you want to see.

Spending $10 billion on R&D, $50 billion

on data centers.

Margins are pretty pretty solid. And

they're converting uh, pretty much more

than the revenue into cash. I guess

they're using it all as leverage. Now,

they are taking on quite a lot of debt,

but their interest cover, which is

basically gives an explanation here. Uh,

how many times the company's profit can

cover the interest bill on its debt. So,

for about 5 years, they could pay for it

with 1 year. This is where most health

companies sit, Winston says. Pay a

little bit of a dividend, not a lot, but

a little bit. And they have this backlog

of orders of $500 billion.

Now, a lot of that comes from OpenAI,

who may or may not have the money to do

it. Anthropic has just secretly filed

for IPO.

OpenAI is going to do the same thing.

So, they might bring in the money to

actually pay out pay pay Oracle that

way. We'll we'll find out. So, these

guys are deep part of the AI story.

Guided for 90 billion revenue this year,

but Larry Ellison, who owns most of it,

you're you know, you're essentially

betting on him. It's a bit like a like a

Musk company. You're betting very, very

much on the founder there.

Uh and they're being very very, very

ambitious. It's really uh something. So,

the risk is obviously also there because

they got to execute. If they don't, you

know, there's no risk-free trade ever.

But, the way I think about it is that

these guys are basically building the

highway for AI.

So, let me show you next two companies

that are building the toll booths for

the very, very same highway. I also want

to say congratulations. You made it way

that

I also want to say congratulations.

You're halfway through the video

already, which is fantastic. Uh so,

you've got the framework now. You've

seen how pre-revenue companies with

government backing work. You've seen the

infrastructure giant um and you're

probably sitting there thinking, "Okay,

I get it. These are interesting

companies, but say knowing Oracle as a

$500 billion of a backlog doesn't tell

me what you should do with your money.

Knowing that Beta has seven FAA

approvals doesn't tell me whether I

should buy it.

And that's the thing, isn't it?

You don't know whether you should buy it

now, whether you should wait, whether

you're too early, whether you're too

late. And if you've bought a huge winner

too late before or you held on as it

destroyed your savings gradually and

slowly and the money poured over to some

chap on Wall Street, you realize by now

that maybe picking the stock or finding

a good stock isn't the hard part. I just

just giving you six here in this video.

Finding them is kind of the easy part.

The hard part is everything else. It's

the entry, it's the exit, the position

size, the discipline, when it drops 30%

and your stomach is in your throat.

That's when That's when you separate

yourself from the masses who are just

hoping and praying and wishing. And

that's what the free session on the

Saturday is about. Uh so, you going to

go to greatestplaybook.com.

I'm going to walk you through the

playbook that sits behind the picks. How

to actually turn stock research into

investments or trades, how to get rid of

that anxiety and replace it with a

system.

Um it'll be free. We'll teach it to you.

That it'll be on Saturday.

One session, about an hour and a half or

2 hours. And the link's in the

description. And no, there'll be no

replay. Don't ask me for one. Now, stock

numero cuatro is Dynatrace, which sounds

exciting, doesn't it? The ticker symbol

is DT. And every company on Earth is

building what? AI systems. AI chatbots,

AI analytics, AI automation, AI

software. And who's watching the AI?

Who makes sure these systems actually

work? Who catches when an AI agent

hallucinates, which is making up?

When it crashes or when it starts

costing the company money. There are

examples of these AI bots just deleting

entire databases, right?

Who deals with this? Dynatrace. They're

the air traffic control for AI. Their

platform monitors, observes, and manages

every piece of a company's digital

world, from the code to the cloud to the

AI agencies, the whole thing. And they

just launched something called Dynatrace

Intelligence. Everything is now about

intelligence, apparently. It is an

agentic AI, which

if you don't know what that means, it is

an AI where you Most of you use AI,

maybe you Google search or something.

You can ask a question and get the

answer, right? Agentic AI is something

that does things on its own. Yeah,

scary, I know, but it's true.

So, they don't just monitor your

problems, they fix them automatically

with no human being there.

And if we look at the company,

it's got a Winston score of 57,

which isn't brilliant, but he's curious.

He says it's a decent business, some

strong pillars. The smart money has sold

it.

You can see that here. Like Trump sold

175k there. Who is Lisa McLean? She's

It's $500 or someone's Someone started a

Go Fund Me page for Lisa. Who is Lisa

McClain? Republican. Well, she's done

1,400 trades, so she's probably all

right. I don't think we really need a Go

Fund Me page. Well, what do you notice?

Where are all the Where's all the

selling happening? It happened up here,

didn't it? Before the stock really

collapsed. Some last some, you know,

suckers who are late. And then what's

happening

since? It's one buy. Just one buy.

So, that's kind of curious, isn't it?

Who's that one buy?

Donald J. Trump. El Presidente.

Um and yeah, he trades a little. 2,300

trades to disclose. And we can be all

those holdings. This is all in the in in

the in the Winston app. But yeah, that's

kind of an interesting one, right? Now,

it's a very small trade for him. So, I

wouldn't bet the ranch on it just

because he owns it. But what did we see?

We see revenue growing. We see R&D

investment going up, which is actually

what you want in a tech company.

They're generating cash, so they're not

going to run out of money ever. And they

have an insanely high margin, which

means whatever they're making is very

good cuz people are willing to pay a lot

for it.

And they've got no debt whatsoever. So,

this is actually a pretty decent company

from where I'm sitting. Doesn't mean you

should run out and buy it.

So, in summary,

they've got plenty of cash, they're

generating cash. Woohoo. Um they also

have a $1 billion

buyback

$1 billion

$1 billion

buyback program,

which means they're going to be less

shares out there, right? So, they got

the the Not the government.

The government, too. Uh management

thinks the stock's undervalued enough to

buy its own shares. Or maybe management

has share options and they want to pump

the stock. Um I'm not saying the the

second is true, but it's a possibility.

And they sell through AWS. AWS is a

marketplace. And they now sell over a

billion dollars through the AWS

marketplace. And revenue is growing. We

expect 2 billion this year. So, the

growth is okay, right? It's not

explosive, but it's okay. So, it's sort

of a slow compounder. It's sort of like

that steady grower.

It's not your immediate moonshot. So,

four stocks down, I still haven't told

you the one I bought. I know I'm mean,

aren't I? Um I still haven't told you my

favorite. So, those are the two that are

coming up next. Tenable Holdings, T E N

B is stock numero five.

Um

and I've been

wanting to tell

and I've been wanting to tell and I've

been wanting to talk to you about this

because it's the one I just bought with

my own money. Now, that doesn't mean you

should buy it. I am not going to tell

you when I sell it, probably.

I may, but you may miss that video. So,

don't buy something just because I'm

buying it. That's not going to get you

anywhere, right?

You also don't know what percentage of

my portfolio it is and all that kind of

good stuff. Risk management is the key

to it. But, let me tell you why I bought

it.

Tenable is a cybersecurity company,

but not in the way most people think

about cybersecurity. Most cybersecurity

companies try to build walls, like

firewalls, antivirus, intrusion

detection.

Tenable does something different. They

show you every crack in the wall before

the hackers find it.

And they call it exposure management.

So, their platform, Tenable One, scans

your entire digital footprint, your

cloud, your code, your AI system, your

IoT devices, everything you have. And it

tells you where you are

vulnerable.

And

here's how bad it is. Here's what to

fix.

And they just launched something called

Hexa AI, which is an AI agent that finds

the vulnerabilities

and then

it tells your team exactly how to patch

them up. And because everybody is

building AI software, the

attack surface and the cracks are

growing exponentially.

And Tenable is the company that maps

that surface. Now, if you look at the

fundamental tip, so a $3 billion

company, Winston Oh um

is concerned about his poor Winston

score. We've had

a lot of government buying in this. Not

huge buys, but you know, Ro Khanna can't

help himself. He buys it every time he

wakes up.

And he was buying it on the way down.

Maybe you should attend our

session on the weekend. We You know, we

might learn something. And then what do

you see? Well, you see an inflection

here, right? You see this stock

recovering very, very nicely.

And that's honestly the reason I bought

it. And that'll make a lot more sense if

you join me on Saturday. Because why

would you buy something that looks on

the face of it like a total loser? It's

down 53%, but it was down, you know, 80%

or something like that. It is for the

simple reason

that as we were collapsing, I wasn't

buying it.

We got some really big spikes here in

selling happening on the way down. And

those were the last people that wanted

to get their F out of the burning

building, but were really late. And then

what changed is that on the way on the

green days, we're now seeing some really

nice volume coming in, which looks to me

like institutional money, fresh money,

who is going, "This looks interesting."

You know, and I like fresh money. Fresh

money, yes.

Uh so, this is something that's already

rebounded quite nicely. Uh I bought it I

think last

Monday. So, that would have been about

about here. 23, so it's $6 higher. But

if it were, and again, no promise of

that, if it were to recover some of the

previous highs of April last 2024, 27%

up, 100% up to the 2022 top. So, think

about this. This is a stock that's

trading where it was trading in 2020.

We basically have no AI in 2020. So, the

demand possibility, the addressable

market is that much bigger, and it

hasn't done bugger at

And these guys are profitable. They're

generating cash. Everybody has to spend

money on cybersecurity.

It is just It's just It's a

That's the tailwind. It's the one budget

line that companies cannot cut, right?

You can delay marketing, you can

postpone product launch, whatever you

can delay.

But AI deployment security for an AI

deployment, you cannot

afford to

skimp on that one.

So, revenue is growing again.

10% year-on-year.

They're going to bring in about a

billion and a bit this year.

And it's a pretty slow growth rate. And

I want to highlight that to you.

So, why did I buy it? Because I believe

the market is underpricing the

cybersecurity tailwind. I can start to

see the money pouring into it. So, I see

an asymmetric risk reward.

Every company is rushing in, creating

essentially places where they can get

attacked. Cybersecurity they cannot cut.

And if growth accelerates, I think this

could re-rate significantly. So, my

money is on this. Well, it doesn't mean

yours should be. Please, please, please,

don't ever buy something just because

I'm buying it. I am wrong. I have

losers, too, and I'll walk you through

that on the weekend, as well. Cuz that's

really important to understand. No one's

got a crystal ball. No one's always

right. But if you understand the roots,

the structure, you have risk management

that is really rock solid, then

your downsides are

limited. And that's really the point.

Now, stock number six

is the one in a way I'm most excited

about. I haven't bought this yet. It's

called 10X Genomics. 10X

>> [laughter]

>> Ticker symbol TXG.

And it could be the most important

company on this list. Let me explain to

you why, because

it might just blow your mind. Right now,

when you go to a doctor, and they think

you might have, you know, some sort of

disease, they take a biopsy or

something, and they look at your tissue

in a microscope, and they can tell you

whether, you know, your cells are good

or bad.

But they can't tell you what those cells

are doing. Which ones are aggressive,

which ones are dormant, which ones are,

you know, going to spread. They're

basically looking at a city from an

airplane and they're trying to figure

out which buildings have people in them.

You can see the buildings, but you can't

see the life inside the building and

whether there's a party going on in

there or something.

Hideous. Now, there's something called

spatial biology.

And it changes that. It lets scientists

see inside inside individual cells at

the molecular level and understand not

just what these cells

are or that they're there,

but what they're doing.

You can see how they're communicating

with each other. And which ones are

dangerous. So, imagine being able to map

every cell in a tumor and know exactly

which ones to target with treatment

years before a traditional test would

catch it.

That's what 10x Genomics is building.

And they're the leader. Now, if you look

at the fundamentals, it's a $3.7 billion

company. Winston is a little concerned

about their data. Revenue is

just, you know, doing anything. Uh

they're spending a fair bit on R&D. They

have cash. They have quite a bit of cash

on hand and they're not burning through

it, which is nice to see. They have

pretty decent margins, which means their

product is something people are willing

to pay for. And they consistently grow

their profit per share. And what they've

done, because I should probably show you

the stock chart, right? It looks a bit

like this. Oh my god, look at the rally.

Look how beautiful. And then you zoom

out and you go, "Eh."

But actually,

this is

this is the potential, right? I'm not

saying it's going to go up 600%, but it

is it is that. It's trading

85% below its high. I say, "Oh, buy and

hold. Buy and hold." Right? Yeah, good

luck with that. Um and what we're seeing

here again is

something I'm going to talk to you more

about on the weekend is is this

heartbeat pattern thing here. It's

looping up quite nicely. we're breaking

out of that here. So, it's kind of got

the hallmark of the things that we're

looking at that we're looking for. But,

these guys have cut expenses a lot.

Their margins have improved. They beat

earnings

by a by a very wide margin in the last

quarter.

So, they're getting lean, right? They

they've given themselves again the the

Ozempic treatment. And there is an

institutional tailwind because they're

launching a new platform in the second

half of this year called Xaira. And

Xaira is that spatial biology platform

that could really grow their addressable

market. So, think of it as the next sort

of generation products, the one that's

designed to take that spatial biology

from the research labs into actual

clinics. So, people's lives will be

saved by this.

They partnered with an AI company called

Bio Optimus to launch something called

Stella, which is a spatial data

initiative that combines basically what

10x does

with AI.

So, it's kind of the spatial biology

plus AI.

Uh and and that's I think the big

opportunity here because uh

humans looking at teeny tiny molecules,

we're going to make mistakes, but AI

will not.

And revenue is

growing. 150 million revenue last

quarter, which is more than we were

expecting.

Uh guidance for the year is now 600

million plus. So, it's a turnaround

story. I I think they've cut the fat,

the top line's growing again while

margins are expanding. So, costs are

going down, revenue's going up, new

product launching, AI partnerships,

which is kind of the setup that we look

for.

What's the risk? It's a turnaround

story.

And

sometimes they turn around once more.

>> [laughter]

>> You know, management goes back to the

good old ways of let's just spend more

money and it'll be fine.

Um just buy a yacht for the business.

But, if it works,

the opportunity could be tremendous. And

that's why it's my favorite. Not because

it's the safest, not because it's the

surest thing, but because the upside, if

the turnaround continues, could be

extraordinary. And almost no one's

talking about it. And that's kind of

where this I see the opportunities

hiding.

So, there we are. We got six stocks.

Congratulations for making it this far.

We got two government-backed frontier

bets, Better RegTech.

We got Oracle, the AI infrastructure

giant. And we got two software toll

booths, Dynatrace and Tenable. And then

the hidden gem that we just talked

about, 10x Genomics. Right. So, you now

know more about these six companies than

99% of retail investors. And none of it

will help you. Because knowing Better

has, you know, a certain backlog isn't a

strategy. Knowing Oracle has got, you

know, $500 billion revenue committed.

Again, this isn't a trade, it's a

headline. Headlines don't make you

money. They make Wall Street money. And

I can tell you right now, some of these

stocks could be massive winners.

Most retail investors will still lose

money on them.

Not because the companies were bad,

because they didn't know the rules. They

didn't have a system. They didn't have a

structure. And if you've bought the

right stock before and still lost money,

you held too long, you got in too late,

you got out too early, you panicked when

it dropped, whatever. You have a

playbook problem.

And that's why I'm going to run that

free live session for you guys on the on

the weekend at greatestplaybook.com.

I'm going to walk you through the exact

playbook, how to turn research into

decisions. And it'll work for you no

matter where you are in the world,

whether you got $500 to your name or

millions of dollars to your name. The

system doesn't care about your balance.

It cares about your process. It cares

about your behavior. So, show up for

yourself. Links in the description. It's

pinned to the comments. Grab yourself a

free seat. Show up with a nice cup of

cocoa and listen and improve your

skills, which is what this is all about.

And if this video's helped you,

send the link to that live session to

someone else who might benefit from

learning the rules, too. Or just send

them this video.

I wish you all the best. Two weeks ago

on this channel,

I gave you four small space stocks

before anyone really was paying

attention to them. Red wire.

Today, that stock's up 163